SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-001296
Filing Date
2022-01-05
Accepted
2022-01-05 08:53:49
Documents
14
Period of Report
2022-01-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm221591d1_8k.htm   iXBRL 8-K 35882
2 EXHIBIT 99.1 tm221591d1_ex99-1.htm EX-99.1 31488
6 GRAPHIC tm221591d1_ex99-1img001.jpg GRAPHIC 9042
  Complete submission text file 0001104659-22-001296.txt   267483

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrna-20220105.xsd EX-101.SCH 3045
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20220105_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20220105_pre.xml EX-101.PRE 22603
8 EXTRACTED XBRL INSTANCE DOCUMENT tm221591d1_8k_htm.xml XML 3698
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 22509534
SIC: 2834 Pharmaceutical Preparations